SCHEMBL6926577

SCHEMBL6926577

Oc1cccc2c1c1cc(Cl)ccc1n2Cc1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
PLA2G2A P14555 1/20 0.42
MDM4 O15151 1/20 0.40
MDM2 Q00987 1/20 0.40
CYP3A4 P08684 4/20 0.40
ALDH1A1 P00352 4/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2C9 P11712 3/20 0.40
CYP2C19 P33261 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
TSHR P16473 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CYP2D6 P10635 2/20 0.40
MAPK10 P53779 2/20 0.40
HIF1A Q16665 1/20 0.40
PTGES2 Q9H7Z7 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
RGS4 P49798 1/20 0.40
RGS8 P57771 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921048 0.91 HDAC1 (0.43) MAPTCYP3A4ALDH1A1CYP1A2CYP2C9
SCHEMBL6924327 0.88 SRC (0.51) MAPTPLA2G2ACYP3A4ALDH1A1CYP1A2
SCHEMBL6923683 0.86 KDM4E (0.44) MAPTPLA2G2AALDH1A1KDM4EMAPK10
SCHEMBL6923669 0.84 SRC (0.50) MAPTPLA2G2AALDH1A1KDM4EHSD17B10
Pyridine SCHEMBL7506032 0.81 SRC (0.44) MAPTPLA2G2ACYP3A4ALDH1A1CYP1A2
SCHEMBL5797962 0.80 PTGER4 (0.50) MAPTPLA2G2ACYP3A4ALDH1A1CYP1A2
SCHEMBL6924605 0.78 MEN1 (0.43) MAPTPLA2G2AALDH1A1TSHRNPSR1
SCHEMBL6921052 0.76 MEN1 (0.43) MAPTPLA2G2AALDH1A1TSHRTDP1
SCHEMBL7723992 0.76 SRC (0.53) MAPTPLA2G2AALDH1A1KDM4ENPSR1
SCHEMBL7505287 0.76 ESR1 (0.44) MAPTPLA2G2AKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1169789-C Aminoalkoxy carbazoles for the treatment of CNS diseases 法玛西雅厄普约翰美国公司 2004-10-06 CN disclosed
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
CN-1372547-A Aminoalkoxy carbazoles for the treatment of CNS diseases UPJOHN CO (US) 2002-10-02 CN disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed